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The Medicines and Healthcare products Regulatory Agency update in 2018 reported
50 fatal fires linked with emollient use. It detailed the fire risk and new advice aimed at
fire service and health care professionals in reporting of such fire incidents and educat-
ing the public on safer use of emollients. This study investigates how this has been com-
municated internally and publicly, with 52 Fire and Rescue Services (FRSs) websites
and, 191 Clinical Commissioning Groups (CCGs), and 21 Local Health Boards (LHBs)
formularies accessed. A Freedom of Information Request (FOIR) was also made, giving
further details of implementations. Our study revealed that 63% of FRSs, 32% of CCGs
and, 72% of LHBs gave no safety advice within their website or formularies. Of the
37% of FRSs and 68% of CCGs that did, only 5% and 4% were sufficiently up to date.
27% of FRSs and 28% of CCGs/LHBs revealed that they had no warning/advice inter-
nally in their FOIR responses and 25% of FRSs and, 35% of CCG/LHBs had not dissemi-
nated advice on using emollient safely to the public. We suggest improvements in
safety campaigns using a multiagency and national approach and recommend organiza-
tions to educate professionals to improve reporting and effective dissemination.
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1 | INTRODUCTION
In 2008, the National Patient Safety Agency (NPSA) issued a warning
about the possible flammability of bandages and other material when
impregnated with emollient products, based on 50% paraffin content or
above.1 A recent Freedom of Information Request (FOIR) from the Brit-
ish Broadcasting Corporation (BBC) described 37 fire deaths linked to
the use of skin emollients in the United Kingdom (UK) from 2010 to
2017.2 The Medicines and Healthcare products Regulatory Agency
(MHRA) in 2018 subsequently described 50 fire deaths involving the use
of emollients.3 However, the number of fatalities is thought to be higher,
owing to underreporting and the lack of awareness within the Fire and
Rescue Services4 and healthcare professionals and, among patients.5 This
is despite the MHRA report, which in part targeted such organizations
and other editorials and articles trying to highlight similar concerns on
the flammability of skin care products when dried into fabrics and cloth-
ing.6-9 There have also been several media accounts2,10,11 and coroners'
reports describing the possible acceleration of fires by emollients, with
the victims usually elderly smokers with reduced mobility.12-17 The coro-
ner's reports state that there is an increased risk of fire when emollients
are soaked into clothing and bedding and recommend that more infor-
mation should be available to patients and healthcare professionals.
The MHRA publication3 requested any fire incidents linked
with emollient use to be reported using their yellow card scheme.
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This triggered, the National Fire Chiefs Council to provide links to the
MHRA advice for use by the Fire and Rescue Services and for public
communication. The MHRA also provided healthcare professionals
with advice on prescribing skin emollient products and how the infor-
mation should be delivered to patients.
The recent message from the MHRA is not to stop or deter people
from using medication, but to help people to use such products in a
safer way. Currently, the MHRA are recommending that labeling and
product information for emollients should include a warning about their
fire risk.3 Their previous guidance only related to products with a paraf-
fin content of 50% or greater but has now changed to include low paraf-
fin content and paraffin free products based on flammability tests.18
The study showed that the mean ignition time is reduced from 60 sec-
onds for blank cotton sheeting to under 10 seconds when contaminated
with a 27.1% paraffin base cream (14.5% white soft paraffin/12.6% light
liquid) and left to dry for 24 hours, using an indirect flame. The vertical
flammability tests also showed quicker ignition times of polyester and
cotton blend sheeting, reducing from 336 to 13 seconds with the same
emollient present and dried for 24 hours. These large reduction in igni-
tion times could have an impact on the possibility for a person to react
quickly enough to remove ignited clothing or bedding especially if
elderly or immobile This also raises concerns about impregnated bed
sheets, surgical dressings, gowns or night wear made of blended fabrics,
such as those used in hospitals or care homes. Blended fabrics exhibit
inherent flame-retardant characteristics, but these results suggest that
using such fabrics for bedding may not mitigate the risk, as proposed in
research based on oil based contaminated flame-retardant materials.19
It is crucial that the appropriate warnings and cautions are com-
municated effectively to the public and within organizations, espe-
cially in view of the wide use and variety of such products. In 2018,
General Practitioners (GPs) in England prescribed over 10.5 million
individual items of emollient and barrier preparations; worth over £70
million.20 Additionally, over-the-counter purchases of these prepara-
tions' accounts for an industry worth over £2.2 billion.21
A study has not yet been carried out on how and if these new
warnings are being distributed within relevant service professions and
subsequently communicated to the public. Therefore, here, we describe
and measure the response to the MHRA guidance on the updated
safety advice and dissemination by public bodies regulating large sectors
of the relevant professional community including the Fire and Rescue
Services, Clinical Commissioning Groups and Local Health Boards.
2 | METHODS
2.1 | Data collection from websites and freedom
of information requests
Fifty-two FRSs were identified from the National Fire Chiefs Council
(NFCC) website22 and 191 CCGs (England), and 21 LHBs (Scotland
and Wales) using the NHS website23-25 and included in this study.
The overall website search of FRSs and CCGs/LHBs for advice on the
safe use of emollients and assessing the quality and currency was
carried out between May 20 and July 04, 2019. Within the FRSs
websites, the search word “emollients,” “cream,” and then
“moisturiser” was used in the homepage search bar and then the rele-
vant results navigated to. For the homepage of CCGs and LHBs, links
to the formulary or prescribing guidelines were navigated to and any
warnings were searched for. If the formulary or prescribing guideline
could not be found, or obvious, a search for “formulary,” “emollient,”
“cream,” and then “moisturiser” was carried out. In the case of CCGs
that used a joint formulary, this was also recorded.
A FOIR was emailed to 51 FRSs and all 191 CCGs, 14 Scottish
LHBs and, 7 Welsh LHBs (that were accountable under the UK's Free-
dom of Information Act 2000) on the August 13, 2019, with
responses collated on September 24, 2019. The request consisted of
four questions based upon the 2018 MHRA report on emollient
flammability:
1. Has this information provided by the MHRA been implemented
across your “organisation” to advise staff?
2. How has this been implemented? Please also provide details of
any future intentions.
3. Has this information provided by the MHRA been implemented
across your “organisation” to advise the public on how to use
emollient skin products safely?
4. How has this been implemented? Please also provide details of
any future intentions.
2.2 | System of scoring the quality of
recommended fire warnings and advice from websites
The parameters used to assess the quality of warning were based upon
the current MHRA published report mirrored by published information
on the NFCC website22 and the British National Formulary.26 The quality
of warning and advice on emollients was scored using the parameters in
Table 1. The number of links on all the websites where the information
was found was also recorded and for FRSs, whether the information was
directed more to the public or to carers was also recorded.
2.3 | Analysis
All the findings (from websites and through the FOIR) and scorings
were recorded in an Excel spreadsheet and summarized in Tables 2
and 3, with Supporting Information containing further details on the
FOIR responses. The resulting levels of warning and corresponding
color code were also presented on a map of Great Britain using QGIS
software (V 3.6.2) and data from Ordnance Survey.27 Also recorded
on the maps are the fatalities linked with emollient use that have been
reported by the MHRA. For the FRSs, the level of warning is represen-
ted in counties as shown in Figure 1. For the CCGs in England, the
scores were applied to each and then averaged and organized into
their corresponding counties of England and represented with the
LHBs for Scotland and Wales in Figure 2.
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3 | RESULTS
3.1 | Fire and rescue services emollient safety
advice on websites
Table 2 and Figure 1 show that across Great Britain (n = 52), 67% of
FRSs were given a warning level of 1 with either insufficient warnings
or no warnings at all (red) in place. 21% had a warning level of
2 (orange); 8% a warning level of 3 (yellow), and only 4% of the FRSs
had good warnings (green) in place within their websites similar to the
MHRA recommendations.
The maps (Figures 1 and 2) include the number of recorded
fatalities linked with skin emollient use and the corresponding
counties in Great Britain. Figure 1 shows a correlation between
the good level of warning (green) available on two FRS website
(West Yorkshire and London) and the high number of linked
fatalities recorded in the county. Figure 2 shows little relation-
ship between fatalities and the level of warnings offered by
TABLE 1 Scoring parameters and the corresponding scoring level and color coding for the available emollient fire warnings and advice within
FRS websites and CCGs/LHBs formularies
Parameter of scoring Scoring level and color codinga
Warning includes paraffin emollients. Green (4) all parameters
Warning also includes non-paraffin emollients. Yellow (3) 4-5 of the parameters
Good explanation of the flammability danger, including dangers of emollients soaked into clothing. Orange (2) 2-3 of the parameters
Gives warnings on the ignition sources for example, naked flame, cigarettes etc. Red (1) 0-2 of the parameters
Details advice on the washing of clothing and that it may not completely remove residue. Grey (0) no formulary available or link broken
Includes link to up to date (2018) MHRA advice
Abbreviations: CCG, Clinical Commissioning Groups; FRS, Fire and Rescue Service; LHBs, Local Health Boards; MHRA, Medicines and Healthcare products
Regulatory Agency.
aShown in Figures 1 and 2.
TABLE 2 Summary of emollient safety advice on Fire and Rescue Services websites in England, Scotland, and Wales
Fire and Rescue Services
in England in Scotland in Wales
Information available on website % Number % Number % Number
No warning on FRS website 63 30 100 1 100 3
Warning on FRS website 38 18 0 0 0 0
Warning directed toward the public 61* 11 0 0 0 0
Warning directed toward carers 39* 7 0 0 0 0
Warning via link to 2018 MHRA publication 11* 2 0 0 0 0
Warning to out of date MHRA publication 17* 3 0 0 0 0
Quality of warning n = 18
Just on paraffin base emollients 83 15 0 0 0 0
Include paraffin free base emollients 17 3 0 0 0 0
Explanation of impregnation into fabrics 94 17 0 0 0 0
Ignition source warning 94 17 0 0 0 0
Advice on laundering 39 7 0 0 0 0
Warning level score n = 48
4 (green) 4 2 0 0
3 (yellow) 8 4 0 0
2 (orange) 23 11 0 0
1 (red) 65 31 100 1 100 3
Range of number of links to the warning 2–6 0 0
Average number of links to warning 3 0 0
Note: England = 48 FRS (8 regions + London); Scotland = 1 FRS and Wales = 3 FRS *n = 18.
Abbreviations: FRS, Fire and Rescue Service; MHRA, Medicines and Healthcare products Regulatory Agency.
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CCGs or LHBs within the related county apart from West
Yorkshire.
3.2 | Clinical Commissioning Groups and Local
Health Boards emollient safety advice in formularies
Table 3 represents the warnings related to the use of emollients
(up to 4th of July 2019) in the NHS across Great Britain, with 32% of
CCGs in England, 69% and 57% of LHBs (Scotland and Wales) having
no warning in their formularies, prescribing guidelines or through
shared formularies following the MHRA publication.3
In England, 51% of CCGs were given a warning level of 1 (red);
31% a warning level of 2 (orange); 13% a warning level of 3 (yellow),
and 5% a warning level of 4 (green). For LHBs in Wales, 71% were
given a warning level of 1 (red); 29% a warning level of 2 (orange),
with no level 3 or 4 scored. Of the LHBs in Scotland, 43% were given
a warning level of 1 (red); 29% a warning level of 2 (orange); no level
3 and 7% a warning level of 4 (green). The study also found little con-
sistency between CCGs in the same county, as an example Essex has
10 CCGs and four were given a warning level of 1 (red); five with a
warning level of 2 (orange); none with a warning level of 3 and one
scoring a warning level of 4 (green). 5% of the NHS (ie, in total) had
good warnings (green) in place within online formularies or prescribing
guidelines similar to the MHRA recommendations. Only 12% had suf-
ficient (yellow) warnings in place, 29% had mostly insufficient (orange)
warnings, and 53% had either insufficient warnings or no warnings at
all (red) in place.
3.3 | Fire and rescue services emollient safety
advice in response to a freedom of information
request
80% of FRS responded to the FOIR (see Supporting Information),
with 27% of responses revealing no implementation of the MHRA
warning internally within their organization, with a similar 25% of
responses with no implementation to the public. This is different to
the 63% found through the website searches; however, a lot of
implementation to FRS personnel was either through internal com-
munication or via training (Figure 3). Similarly, public information
was communicated via home safety advice rather than through FRS
websites. Therefore, we were unable to assess if these different
implementations were up to date for this study. Table 2 includes
the scoring of the quality of warning and if available, whether it
was up to date, with the largest percentages (65%, 100%, and
100%) of FRSs in Great Britain placed in the lowest score category
(Figure 1).
TABLE 3 Summary of emollient safety advice in the formularies across England, Scotland, and Wales
Information available on website
CCGs in England Health boards in Scotland Health boards in Wales
% number % number % number
No warning in formulary, prescribing guidelines or joint
formulary via CCG website
32 62 69 9 57 4
Warning in formulary, prescribing guidelines or joint
formulary via CCG website
68 129 38 5 43 3
Warning via a link with out of date information 53* 79 23† 3 0ǂ 0
Warning via link to 2018 MHRA publication 36* 47 0† 0 0ǂ 0
Quality of warning n = 129 n = 8 n = 3
Just on paraffin base emollients 69 89 80 4 100 3
Include paraffin free base emollients 29 38 20 1 0 0
Explanation of impregnation into fabrics 73 94 60 3 67 2
Ignition source warning 55 71 20 1 67 2
Advice on laundering 16 21 20 1 0 0
Warning level score n = 191 n = 13 n = 7
4 (green) 5 9 0 0 0 0
3 (yellow) 13 24 7 1 0 0
2 (orange) 31 60 0 0 29 2
1 (red) 51 98 70 9 71 5
0 (No formulary available or broken link) 0 0 23 3 0 0
Range of number of links to the warning 2-5 2–4 3–4
Average number of links to warning 3 3 3
Note: England = 191 CCGs; Scotland = 14 health boards and Wales = 7 health boards *n = 129 †n = 8 ‡n = 3.
Abbreviations: CCG, Clinical Commissioning Groups; MHRA, Medicines and Healthcare products Regulatory Agency.
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3.4 | Clinical Commissioning Groups and Local
Health Boards emollient safety advice in response to a
freedom of information request
88% of CCGs and LHBs responded to the FOIR (see Supporting Infor-
mation) with 16% revealing they had not implemented the MHRA guid-
ance to health care professionals within their organization and 12%
describing that this was the responsibility of GPs and pharmacists.
A total of 28% described having no warning internally within
their organization (see Supporting Information) or that it was GPs or
pharmacist's responsibility (Figure 4) which is similar to our website
search findings (32%). In addition, 35% of CCGs and LHBs (see
Supporting Information) stated they had not implemented any infor-
mation on using emollients safely to the public and 48% it was the
responsibility of GPs and pharmacists. The CCGs/LHBs that did
implement the warning to the public, mostly did this via patient
F IGURE 1 Quality of advice based on
MHRA emollient fire warnings on FRS
websites across counties of England,
Scotland, and Wales, and fatality numbers
linked with emollient use. FRS, Fire and
Rescue Service; MHRA, Medicines and
Healthcare products Regulatory Agency
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leaflets (Figure 4); however, we were unable to check if this included
the new up to date advice. Table 3 includes the scoring of the quality
of warning and if available, whether it was up-to-date, with the larg-
est percentages (51%, 70%, and 71%) of CCGs and Health boards in
Great Britain placed in the lowest score category (as shown in
Figure 2).
When comparing FRSs to CCGs and LHBs only 38% FRSs
websites included a warning compared to 68% of formulary/
prescribing websites. When a warning was present on FRS websites
in England, only 17% included paraffin-free emollients compared to
29% across CCGs. However, 94% of FRSs (Table 2) included a good
explanation of impregnation into the fabric and ignition sources
compared to 73% and 55%, respectively, across CCGs in England
(Table 3).
There have been various ways that CCG and LHBs have
implemented the information from the MHRA (Figure 4) with some
F IGURE 2 Quality of advice based on
MHRA emollient fire warnings in the
formularies of CCGs and LHBs across
counties of England, Scotland, and Wales
and fatality numbers linked with emollient
use. CCG, Clinical Commissioning Groups;
LHBs, Local Health Boards; MHRA,
Medicines and Healthcare products
Regulatory Agency
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describing and sending screenshots of the warning being added to
Scriptswitch and other prescribing software for healthcare profes-
sionals. Some CCG/LHBs had described that the implementation had
been carried out by updating formularies/guidelines; however, a larger
percentage (56%) were using the old 2016 MHRA advice or NPSA
warning. This reflects the findings of website searches, which found
53% had a warning via a link to out of date information. This was also
the case of FRS webpages and FOIR response for advising the public
with 45% still using the old MHRA advice.
32% and 37% of FRSs detailed that that had no future plans to
implement this further internally to personnel or the public, respectively
(see Supporting Information). Where, 56% and 87% of CCGs/LHBs had
no future intentions for implementation to health care professionals or
the public, respectively. Those who do have future plans describe dis-
semination mostly via prescribing updates or internal communication
for professionals and patient leaflets for public information. A few FRSs
and CCGs/LHBs described their implementation or future intentions of
disseminating advice on the fire risk of emollients by partnering with
each other. The FOIR results are summarized in a table in Supporting
Information, but they did not change the scoring or maps. Some CCGs
had updated the advice available after July 4th when our public website
search concluded and therefore were not included in our scoring.
4 | DISCUSSION
This study found overall that warnings were poor across both FRSs and
NHS services in Great Britain. Only 4% of FRSs websites contained the
correct and most current information as published by the MHRA. Simi-
larly, only 5% of health services produced a sufficient warning alongside
emollient prescribing information. Extensive searching of FRSs and
CCG/LHBs websites revealed differences in not only the format but
also the level of information presented. In addition, navigation of CCG
and LHB formularies to the correct information was often complicated
and not user friendly for health care professionals and the public. Simi-
lar findings were also commented on in a study on the variations in the
structure of emollient formularies on CCG websites leading to confu-
sion for prescribers and patients.28 The FOIR reaffirmed the high level
of variation within FRSs and healthcare services and how they have
implemented the MHRA update, even though the National Health and
Care Excellence have published guidelines to reduce variation in pre-
scribing.25 This study shows that MHRA warning updates have not
been disseminated adequately to help in providing information to
healthcare providers, FRSs, and the public.
When carrying out the scoring (Table 1) on the level of warning
based on the MHRA published report, low scores were given when
F IGURE 3 Summary of
results of Freedom of Information
Request responses based on
Medicines and Healthcare
products Regulatory Agency
advice disseminated to fire
service personnel
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just a link to the MHRA warning was available, as it did not give a fur-
ther explanation or clarity and often added more cumbersome links.
Low scores were also awarded when there the link was to the out of
date 2016 MHRA warning (only including paraffin or high paraffin
base emollients) or to the archived/old NPSA website. Similar findings
via the responses to the FOIR confirmed our scoring, with some CCGs
and LHBs describing they had included information in their formulary,
but on inspection, this was still out of date, commonly from the older
2016 MHRA report. In comparison, if a CCG website gave further
details on the formulary site supplementary to the prescription infor-
mation, these were reflected in a higher score, as healthcare profes-
sionals and the public would be made fully aware of the risk. As part
of the scoring level, paraffin free emollients should also be included in
warnings, as this mirrors the most up to date alert from the MHRA. If
the warnings on FRSs or CCGs/LHBs websites only included paraffin-
based emollients or above 50% paraffin content, these were scored
lower, as this could lead to the increased use of lower paraffin content
or non-paraffin-based emollients, which still pose a fire risk.
There are some limitations to the evaluation of NHS formularies
and FRSs websites. Whilst websites were searched extensively, there
is the possibility that information could be missed. We tried to limit
this and to account for any missed information by conducting the
FOIR. In addition, this research does not include any assessment of
the warnings or advice regarding over the counter emollients and only
includes those prescribed. All information via the website search is
correct up to July 04, 2019 and due to the nature of the data retrieval
process there will be slight variability in the information given on FRS
websites or formularies during the time frame it was collected. All
information via the FOIR is correct up to September 24, 2019. Our
study findings from the initial formulary and website search and sub-
sequent scoring had not changed with regard to the additional results
from the FOIR.
The responses of the FOIR to FRSs and CCGs/LHBs gave more
information on how the safety advice on using emollients had been
delivered differently to professionals and the public via the websites
or formularies. A large percentage of responses described the
methods, with some examples given that is, patient/public information
leaflets. However, we were unable to access most of the methods
described and therefore unable to measure if the information was up
to date. A lot of responses from CCGs and LHBs stated that it was the
responsibility of GPs and pharmacists to inform the public. Therefore,
we were unable to assess the information given via this route, but
F IGURE 4 Summary of
results of Freedom of Information
Request responses from CCGs/
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useful information when considering potential targets within the
healthcare professions in future safety campaigns. Many responses to
the FOIR from FRSs indicated that the information was delivered via a
newsletter or bulletin or delivered in internal training programs.
Although newsletters and bulletins are still useful dissemination, it is
more of a “read once” document, so it could be suggested that these
are reissued to make sure the message is reiterated and distributed to
new employees. Some FOIR to FRSs responded by detailing how
advice is given during home safety visits and therefore important that
safety campaigns should also target staff who offer fire risk advice to
the public.
5 | CONCLUSIONS
Our study indicates in 2019 many Fire and Rescue Services, Clinical
Commissioning Groups and Local Health Boards were neither promot-
ing fire safety issues about emollients within their organizations nor
externally to the public; this was despite the regulatory recommenda-
tion by the MHRA in late 2018. Much of the advice, which was identi-
fied, was outdated, incorrect or insufficient and some organizations
stated they had no plans in place to improve this situation.
Our study showed that in areas where there was a higher number
of fire fatalities linked with emollients, the quality of fire safety advice
shown on the FRSs website was better. However, this was not
reflected on CCG and LHB websites in the same area and suggested
more collaborative partnership with FRS might improve the fire safety
risk awareness of the public and those working within organizations.
A number of organizations also responded to the FOIR suggesting
that there was a need for consistent and clear safety advice. This
would not only support them to raise better awareness within their
organizations, but also help to identify fatalities where emollients had
been involved in the development of the fire thereby ensuring better
reporting and recording of incidents. This information would also
enable a more accurate understanding of the fire risks, which could
facilitate future targeted public campaigns and help save lives.
The National Consensus Statement (2016) signed by the NHS,
Public Heath England, Local Government and Chief Fire Officers
Association and Age UK, stated that health and well-being outcomes
could improve by working together on intelligence-led, early interven-
tion prevention strategies. The Working Together report29 also
encouraged local health and social care services to maximize opportu-
nities with their local FRS, identifying common risk interventions for
vulnerable people.30
Our research and other intelligence-led data have since been used
to inform a national campaign about emollient safety. Using a multi-
agency approach,31 the campaign was delivered in July 2020 by the
MHRA, the National Fire Chiefs Council and a number of health, care
and academic sector stakeholders. Several website resources were
developed for health and care providers enabling clear and consistent
messaging. A toolkit for FRSs, containing training and advice and
information about working in partnership with local health
organizations was also developed. These resources, further research,
and the commitment of partners should ensure the future sustainabil-
ity and consistency of emollient fire safety messaging.
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